MannKind Corp (MNKD) stock

MNKDNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30273% above fair value

$4.13−0.03 (-0.72%)

Close on Nov 13, 2026Market cap $1.33BP/E –Yield –

MannKind enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

MannKind's enterprise value was $1.19B on Nov 11, 2026, against $1.38B a year earlier. Over the last 5 years it ranged from $454.76M to $1.69B, with a median of $1.04B.

Enterprise Value at the end of each year

Period	Period end	Value	Change
2026	Nov 11, 2026	$1.19B	-19.8%
2025	Dec 31, 2025	$1.48B	-2.7%
2024	Dec 31, 2024	$1.52B	+81.1%
2023	Dec 29, 2023	$840.12M	-31.2%
2022	Dec 30, 2022	$1.22B	+28.0%
2021	Dec 31, 2021	$954.52M	+20.5%
2020	Dec 31, 2020	$792.21M	+266.4%
2019	Dec 31, 2019	$216.21M	+36.3%
2018	Dec 31, 2018	$158.62M	-28.8%
2017	Dec 29, 2017	$222.83M	-17.7%
2016	Dec 30, 2016	$270.62M	-52.8%
2015	Dec 31, 2015	$573.55M	-70.5%
2014	Dec 31, 2014	$1.94B	+28.1%
2013	Dec 31, 2013	$1.52B	+3677.7%
2012	Dec 31, 2012	$40.19M	-86.8%
2011	Dec 30, 2011	$305.56M	–